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Bioinformatics evolved to become a recognized scientific
discipline during the last decade of the twentieth century,
due in part to the Human Genome Project and the
introduction of microarray expression profiling, both of
which involved critical computational activities. By 2000,
the National Institutes of Health had established the
Biomedical Information Science and Technology Initiative
(BISTI), which defined bioinformatics as “Research,
development, or application of computational tools and
approaches for expanding the use of biological, medical,
behavioral or health data, including those to acquire, store,
organize, archive, analyze, or visualize such data [1].”
Otherwise stated, the methods of bioinformatics allow the
biomedical scientist to more completely interpret his data.
Bioinformatics was already an important aspect of ophthal-
mic and vision research in 2000. For example, following
early descriptions of microarray expression profiling in the
mid 1990s [2], this methodology was quickly applied to
studies of development and aging of the retina [3,4]. The
current issue of the Journal of Ocular Biology, Diseases
and Informatics highlights the role that bioinformatics is
playing in various fields of eye-related research today.
Scientific reports and reviews contributed from an interna-
tional group of laboratories demonstrate the use of different
computational techniques in studies of normal biology and
diseases of the eye.
One could easily argue that the most significant break-
throughs in the field of ocular genomics within the last
5 years pertain to age-related macular degeneration (AMD).
In 2005, descriptions of the association between single-
nucleotide polymorphisms (SNPs) in the complement factor
H (CFH) gene and AMD [5–8] were headline articles in
both the scientific and popular literature. Manifestations of
AMD differ according to ethnicity, however. In Japanese
persons, in comparison to the predominantly Caucasian
populations that were studied in these landmark studies,
relatively more cases of AMD are of the “wet” phenotype,
including the variant known as polypoidal choroidal
vasculopathy, and relatively less cases are “dry”. In this
issue, Goto and Akahori et al. [9] report results of a
genome-wide scan in 200 Japanese patients with typical
wet or polypoidal choroidal AMD and a similar number of
unaffected control subjects. They use microarrays designed
to detect approximately 500,000 SNPs, and in addition,
consider SNPs not represented on the array, but previously
associated with AMD. By applying standard association
statistics to data thus obtained, they make the significant
observation that associations of AMD with SNPs in the
AMRS2/HTRA1 region are considerably stronger than
associations with SNPs in the CFH region in the Japanese
population.
The issue contains four papers that illustrate the
application of microarray-based transcriptomic profiling in
different fields of ocular research. Kozulin and Provis [10]
demonstrate that gene expression profiling by oligonucle-
otide array may yield substantial information from rare
tissue samples. Using arrays with probes designed to detect
over 47,000 transcripts, they characterize gene expression
in the human macula during mid-gestation. In addition to
standard processing of data generated from macular versus
nasal and peripheral retinal tissue (i.e., normalization and
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secondary analyses that include biological process cluster-
ing and pathway analysis. These additional analyses
provide fascinating observations about macular develop-
ment, including the high expression of multiple cell
adhesion molecules in this region of the retina. As is
common in microarray studies, novel observations stimu-
late new hypotheses for future investigations; the authors
suggest that adhesion molecules may participate in the
formation of retinal circuitry, in axon guidance, and/or in
protection of the macula against the retinal stretch that
occurs during development.
Two reports discuss the use of gene expression micro-
array to elucidate the pathogenesis of retinal vascular
diseases. Tea et al. [11] use oligonucleotide arrays
representing approximately 27,000 genes, to study retinal
gene expression early in the course of the murine model of
retinopathy of prematurity that is known as oxygen-induced
retinopathy. When comparing transcriptomes, differential
gene expression may be analyzed by one of two
approaches: according to fold-change (often set at
2-fold or 1.5 fold); or according to statistical significance
(often defined as false discovery rate below 5%). In this
work, both criteria are applied, and fold-change yields the
most informative results. The authors find alterations in
levels of multiple transcripts regulated by hypoxia-
inducible factor 1-alpha in retinas of neonatal mice exposed
to cyclic hyperoxia in comparison to non-exposed control
animals. As anticipated, more transcripts are differentially
expressed in the retina of the susceptible Sprague-Dawley
strain than the resistant Fisher 344 strain. Freeman et al.
[12] employ similar microarrays to study gene expression
after established hyperglycemia in two different models of
diabetic retinopathy in the C57BL/6J mouse. Disease is either
induced by exposure to streptozotocin or arising spontane-
ously in mice heterozygous for the Ins2
Akita mutation. The
investigators perform secondary network analyses to classify
genes that are differentially expressed following exposure to
hyperglycemia into functional groups. The importance of
considering different models is clear from the finding that
different networks predominate in each model: in Ins2
Akita
heterozygote mice, inflammatory processes are identified; in
streptozotocin-exposed mice, genes with known responsive-
ness to diabetes are highlighted. Apart from providing
insights into the development of the disease, the authors
justifiably stress the relevance of their work as a method for
discovery of new biomarkers of disease.
Ocular toxoplasmosis is one of the most common retinal
infections in both Western and developing nations, with the
potential to cause irreversible blindness [13]. Many basic
aspects of the interaction between the host and the causative
protozoan, Toxoplasma gondii, remain poorly understood.
However, microarray profiling has recently been applied to
this subject, and important advances in this field have
occurred. Brown and Blader [14] review findings from
these expression profiling studies, covering topics that
include: determinants of parasite virulence; replication of
the parasite within a host cell; conversion between the
actively replicating tachyzoite form and the dormant
bradyzoite form; and host immune responses to limit the
severity of the ocular pathology.
Shotgun proteomics is an emerging profiling technology,
offering the possibility of identifying thousands of proteins
within a complex biological sample. Wilmarth et al. [15]
present a new “proteomic analysis workflow pipeline” for
identification of proteins contained in tissue samples that
have been first digested with trypsin and subsequently
subjected to multi-dimensional chromatographic separation
and tandem mass spectrometry. To illustrate their approach,
the authors profile lens proteins from human, mouse, cow
and chicken. They employ sequence-reversed decoy data-
bases and a discriminant function transformation of
SEQUEST software to distinguish real from false peptide
and protein identifications, and they consider strategies
involving two public protein databases—the International
Protein Index and UniProt—and tryptic versus no-enzyme
searches. Using this method, the authors identify novel lens
crystallins, as well as non-crystallin proteins, that are not
detected by the more conventional gel-based 2-dimensional
electrophoresis.
Metabolomics is the study of low molecular weight
metabolites within a biological sample. Young and Wallace
[16] review this relatively under-utilized technology, in-
cluding an appropriate statistical method for data analysis,
known as principal component analysis, which is also
useful in gene expression microarray studies. The field of
metabolomics has pushed ahead recently as a result of
advances in nuclear magnetic resonance and mass spec-
trometry, and has great potential to identify clinically
relevant biomarkers. Most notably the methodology has
been used to successfully predict the degree of coronary
stenosis in human subjects. [17] The authors also discuss
the use of metabolomics for the differential diagnosis of
inflammatory eye disease.
In any bioinformatics study, the quality of the output
data are limited by the quality of the input data. One aspect
of quality assurance in microarrays is addressed by
Harrington et al. [18], who present a method for analysis
of RNA quality that relies on bioanalyzer electrophero-
grams. They illustrate this method with analyses of RNA
extracts that have been obtained from various ocular cells
and tissues. Of particular relevance to eye-related studies,
the authors highlight the presence of unusual RNA peaks in
lacrimal gland and acinar samples. They attribute these
peaks to highly abundant transcripts associated with the
secretory function of the tissue, identifying one of these as
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working with RNA isolates from whole blood, which
contain high levels of hemoglobin transcript, these
secretion protein transcripts may reduce the sensitivity
of microarray studies of lacrimal cells and tissues. The
authors suggest that measures to specifically prevent the
labeling of these transcripts may improve the quality of
t h eo u t p u td a t ai nt h i ss e t t i n g .
As the eight papers in this issue illustrate, bioinfor-
matics is a powerful tool in diverse studies of ocular
biology and eye disease. Although the issue focuses on
the application of bioinformatics to molecular data that
have been generated in genomic, transcriptomic, proteomic
and metabolomic studies, computational approaches also
benefit other areas of eye-related research, including, for
example, investigations that involve image analysis.
Clearly, the power of the tools lies in the software, and as
more sophisticated software programs are developed, one
canexpect toobtaineven more information from one’sdata
sets. In order for such development to occur in ophthalmic
and vision research, however, it is vital that ocular
scientists maintain collaborations with statisticians and
computer programmers throughout the course of their
investigations.
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